Bookmark and Share

Compound Summary for: CID 9933475

cediranib

Also known as: Recentin, 288383-20-0, AZD2171, AZD 2171, AZD-2171, S1017_Selleck, Kinome_3318, Cediranib (USAN/INN), UNII-NQU9IPY4K9
Molecular Formula: C25H27FN4O3   Molecular Weight: 450.505283   InChIKey: XXJWYDDUDKYVKI-UHFFFAOYSA-N
The novel indole-ether quinazoline AZD2171 is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro. It is being developed clinically as a once-daily oral therapy for the treatment of cancer.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _